Pharmacological advances have transformed the management of diabetes, enabling better glycemic control and reduced complications. This book examines the pharmacology of diabetes treatments, including insulin analogs, oral hypoglycemics, and emerging therapies like GLP-1 receptor agonists and SGLT2 inhibitors. It discusses personalized medicine approaches, patient adherence, and the integration of pharmacological treatments with lifestyle modifications. A comprehensive guide for clinicians and researchers, it highlights strategies for improving outcomes in diabetes care.
Olivia Garza is a distinguished dermatologist specializing in the role of pharmacology in treating diabetes-related skin conditions. Her research explores how diabetic medications impact skin health, addressing issues such as diabetic dermopathy, infections, and impaired wound healing. Olivia has authored numerous studies on optimizing pharmacological therapies to manage both diabetes and its dermatological manifestations effectively. She has developed comprehensive treatment protocols that integrate diabetes management with dermatological care.